型号:
产品价格:电议      采购度:1588      原产地:美洲
发布时间:2021/7/24 3:24:05 所属地区:上海 上海市
简要描述:
Atorvastatin hemicalcium salt (CI-981) 是一种口服活性的 3-羟基-3-甲基戊二酰辅酶A (HMG-CoA) 还原酶抑制剂,具有有效降低血脂的能力。Atorvastatin hemicalcium salt 以 IC50分别为 μM 和 μM 来抑制人 SV-SMC 增殖和侵袭。
标签:Lipitor
产品详情
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 134523-03-8
MCE 站:Atorvastatin hemicalcium salt
产品活性:Atorvastatin hemicalcium salt (CI-981) 是一种口服活性的 3-羟基-3-甲基戊二酰辅酶A (HMG-CoA) 还原酶抑制剂,具有有效降低血脂的能力。Atorvastatin hemicalcium salt 以 IC50分别为 0.39 μM 和 2.39 μM 来抑制人 SV-SMC 增殖和侵袭。
研究领域:Metabolic Enzyme/Protease | Autophagy | Apoptosis
作用靶点:HMG-CoA Reductase (HMGCR) | Autophagy | Ferroptosis
In Vitro: Atorvastatin treatment decreases apoptosis of myocardial cells by down-regulating GRP78, caspase-12 and CHOP expression in myocardial cells after myocardial infarction, and the endoplasmic reticulum (ER) stress is activated in response to heart failure and angiotensin II (Ang II) stimulation.
In Vivo: Atorvastatin (20-30 mg/kg; oral gavage; once a day; for 28 days; ApoE?/? mice) treatment significantly reduces endoplasmic reticulum (ER) stress signaling proteins, the number of apoptotic cells, and the activation of Caspase12 and Bax in the Ang II-induced ApoE-/- mice. Proinflammatory cytokines such as IL-6, IL-8, IL-1β are all remarkably inhibited after Atorvastatin treatment.
相关产品:Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | Apoptosis Compound Library | Immunology/Inflammation Compound Library | Metabolism/Protease Compound Library | FDA-Approved Drug Library | CNS-Penetrant Compound Library | Autophagy Compound Library | Anti-Aging Compound Library | Drug Repurposing Compound Library | Ferroptosis Compound Library | Anti-COVID-19 Compound Library | NMPA-Approved Drug Library | Endoplasmic Reticulum Stress Compound Library | Pyroptosis Compound Library | Orally Active Compound Library | FDA Approved & Pharmacopeial Drug Library | Drug-Induced Liver Injury (DILI) Compound Library | Erastin | Ferrostatin-1 | Cisplatin | Cycloheximide | RSL3 | Acetylcysteine | Deferoxamine mesylate | SP600125 | Necrostatin-1 | Rosiglitazone | SB 202190 | Curcumin | Hemin | (-)-Epigallocatechin Gallate | TBHQ | Simvastatin | Bardoxolone methyl | U-73122 | Pifithrin-α hydrobromide | Lovastatin | Trolox | Eprenetapopt | L-Glutathione reduced | Pioglitazone | Deferiprone | NADPH tetrasodium salt | Artesunate | BAY 11-7085 | iFSP1 | Baicalein
品牌介绍:
• MCE (MedChemExpress) 拥有数百种全球独家化合物,我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物;
• 10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果;
• 专业团队跟踪*新的制药及生命科学研究进展,为您提供全球*新的活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。
更新时间:2024/1/2 10:14:41
留言咨询
温馨提示
1.遵守中华人民共和国有关法律、法规,尊重网上道德,承担一切因您的行为而直接或间接引起的法律责任。
2.请您真实的反映产品的情况,不要捏造、诬蔑、造谣。如对产品有任何疑问,也可以留言咨询。
3.未经本站同意,任何人不得利用本留言簿发布个人或团体的具有广告性质的信息或类似言论。
相关新闻
相关产品